JPMorgan Chase & Co’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-286,447
| Closed | -$27.9M | – | 3638 |
|
|
2015
Q1 | $27.9M | Buy |
286,447
+57,107
| +25% | +$5.57M | 0.01% | 1124 |
|
|
2014
Q4 | $21.3M | Buy |
229,340
+112,909
| +97% | +$10.5M | ﹤0.01% | 1256 |
|
|
2014
Q3 | $8.01M | Sell |
116,431
-1,800
| -2% | -$124K | ﹤0.01% | 1788 |
|
|
2014
Q2 | $12.4M | Buy |
118,231
+4,830
| +4% | +$506K | ﹤0.01% | 1595 |
|
|
2014
Q1 | $9.41M | Buy |
113,401
+50,875
| +81% | +$4.22M | ﹤0.01% | 1725 |
|
|
2013
Q4 | $4.05M | Buy |
62,526
+52,888
| +549% | +$3.42M | ﹤0.01% | 2146 |
|
|
2013
Q3 | $611K | Sell |
9,638
-8,361
| -46% | -$530K | ﹤0.01% | 3228 |
|
|
2013
Q2 | $756K | Buy |
+17,999
| New | +$756K | ﹤0.01% | 3058 |
|